Europe Infectious Diseases Diagnostics Market

Europe Infectious Diseases Diagnostics Market Study Analysis:

Diagnostics play a vital role in determining the direction of any medical treatment. For infectious diseases, diagnosis helps in the diagnosis of diseases due to a pathogenic infection. The world of diagnostics is evolving rapidly and the European market for infectious disease diagnostics has been growing steadily in recent years. The diagnosis involves a variety of methods to test for the presence of foreign antigens using a variety of diagnostic tools.

According to a latest market research report, Europe Infectious Diseases Diagnostics Market Size is anticipated to grow at a CAGR of approximately 4% from 2018 to 2025, and it is estimated that the regional market which valued at USD 4,423 Million in 2018 is relied upon to achieve USD 6,037 Million by the end of 2025.

Growth Opportunities, Challenges and Restraints 

Infectious diseases are spreading due to lack of awareness of personal hygiene, minimal health expenditure and lack of effective medical services. The increase in the number of cases of infectious diseases in developed economies should also stimulate market growth. This has led manufacturers to invest in emerging economies. These companies are making efforts to develop and commercialize profitable tools for the diagnosis of infectious diseases.

The increase in the prevalence of chronic diseases is one of the key determinants of the market for infectious diseases diagnostics in Europe. The increase in research and development, combined with the development of new technologies, should lead to the growth of the market. According to the World Health Organization (WHO) in 2015, there were an estimated 32,000 deaths from tuberculosis and an estimated 323,000 new cases of tuberculosis in Europe. In addition, about 323,000 cases of TB in this region include 27,000 cases of HIV infection.

Disease diagnoses are used to confirm disease in the form of a rapid and accurate test result. Epidemics of infectious diseases are spreading throughout the region, leading to an increase in the demand for diagnostic tests. In addition, the incidence of malaria, influenza, AIDS and other diseases is also increasing, which creates a great demand for the regional market. With a majority of physicians adopting the evidence-based treatment method, diagnostic kits for infectious diseases are more likely to gain strength during the prognosis period.

Many government-funded programs around the region increasingly offer free exams and exams to increase public awareness, accurately diagnose diseases and reduce the risk of infection. Such initiatives should stimulate market growth in the coming years. However, diagnostic kits are expensive and manufacturers still have a poor distribution channel to operate in emerging economies. These two factors should be the main obstacles to the rapid growth of the European market for the diagnosis of infectious diseases.

Regional Existence of Europe Infectious Diseases Diagnostics Market

The geographical segmentation of this regional market includes Germany, Italy, Spain, the U.K. and France. Europe held the second largest share of this market and will expand with a significant growth rate in the coming years. This growth rate can be attributed to the growing adoption of premium diagnostic techniques that would sustain the market share of infectious disease diagnostics in the developed economies of this region.

Some of the promising companies leading the Europe Infectious Diseases Diagnostics Market:

• Becton
• Dickinson and Company
• Cepheid Inc.
• Abbott Laboratories
• BioMérieux SA
• Hologic Inc.
• Danaher Corporation
• Thermo Fisher Scientific Inc.
• Roche Diagnostics
• Alere Inc.
• DiaSorin S.p.A.
• Quidel Corporation
• Bio-Rad Laboratories Inc.

This research report includes following segmentation for the Europe Infectious Diseases Diagnostics Market size and forecast 2018 - 2025

Europe Infectious Diseases Diagnostics Market - By Product

• Instruments
• Reagents
• Services
• Software

Europe Infectious Diseases Diagnostics Market - By Application

• Hepatitis B
• Hepatitis C
• Human Immunodeficiency Virus (HIV)
• Tuberculosis (TB)
• Chlamydia Trachomatis
• Neisseria Gonorrhoeae (CT / GN)
• Human Papillomavirus (HPV)

Europe Infectious Diseases Diagnostics Market - By Technology

• PCR
• INAAT
• Dna Sequencing
• Hybridization

Europe Infectious Diseases Diagnostics Market - By End User

• Hospitals
• Laboratories

Europe Infectious Diseases Diagnostics Market – By Region

• United Kingdom
• Germany
• France
• Italy
• Spain